Search Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapySolid TumorsProtocol groupradiotherapyUrologic OncologyDiseaseBladder CancerSubgroupICD10C67.-MeSHCarcinoma, Transitional CellUrinary Bladder NeoplasmsUrogenital NeoplasmsUrologic NeoplasmsSequenceChemotherapyChemo-substanceCapecitabineCisplatinFluorouracilGemcitabineMitomycinChemo-substanceCapecitabineCisplatinFluorouracilGemcitabineMitomycinChemo-substanceCapecitabineCisplatinFluorouracilGemcitabineMitomycinChemo-substanceCapecitabineCisplatinFluorouracilGemcitabineMitomycinNo. Substances12 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesium sulfatePotassium chlorideSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesium sulfatePotassium chlorideSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesium sulfatePotassium chlorideSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesium sulfatePotassium chlorideNo. Substances26Protocol classificationTherapy classificationalternativecurrent standardIntensityStandard doseTherapy indicationFirst lineTherapy phaseTherapy intentioncurativeRisksEmetogenicity (ASCO)Emetogenicity (MASCC/ESMO)Gastrointestinal ToxicityRash only studiesPublicationAuthorChoudhury ACoppin CMde Haar-Holleman AJames NDiseaseHarnblasenkarzinom, muskelinvasiv, nicht metastasiert, ECOG 0-2Muskelinvasives Harnblasenkarzinom, cT2-cT4b, cN0-N3, cM0 Urothelkarzinom, cT2-4a cN0-2/x cM0/xUrothelkarzinom T2-3, N0, M0 nach transurethraler ResektionOriginFront the British Columbia Cancer Agency Vancouver Cancer Centre, CanadaThe Christie NHS Foundation Trust, Wilmslow Rd, Manchester, United KingdomUniversitair Ziekenhuis Brussel, Brussels, Belgium, BlaZIB study University of Birmingham, School of Cancer Sciences, UKProtocols in Revision 4 protocols foundProtocols under revision.Capecitabine 825 / Mitomycin 12 / Radiation, Bladder Cancer (PID2505 V1.0)Cisplatin 100 / Radiation, Bladder Cancer (PID1668 V1.1)Fluorouracil 500 / Mitomycin 12 / Radiation, Bladder Cancer (PID949 V1.0)Gemcitabine 100 / Radiation, Bladder Cancer (PID2213 V1.0)
